Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 1
2012 1
2013 1
2014 2
2015 3
2016 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy of amiodarone in patients with atrial fibrillation with and without left ventricular dysfunction: a pooled analysis of AFFIRM and AF-CHF trials.
Cadrin-Tourigny J, Wyse DG, Roy D, Blondeau L, Levesque S, Talajic M, Andrade JG, Dubuc M, Thibault B, Guerra PG, Macle L, Rivard L, Khairy P. Cadrin-Tourigny J, et al. J Cardiovasc Electrophysiol. 2014 Dec;25(12):1306-13. doi: 10.1111/jce.12535. Epub 2014 Oct 7. J Cardiovasc Electrophysiol. 2014. PMID: 25181386 Clinical Trial.
Blood Pressure and Atrial Fibrillation: A Combined AF-CHF and AFFIRM Analysis.
Tremblay-Gravel M, White M, Roy D, Leduc H, Wyse DG, Cadrin-Tourigny J, Shohoudi A, Macle L, Dubuc M, Andrade J, Rivard L, Guerra PG, Thibault B, Talajic M, Khairy P. Tremblay-Gravel M, et al. J Cardiovasc Electrophysiol. 2015 May;26(5):509-14. doi: 10.1111/jce.12652. Epub 2015 Apr 20. J Cardiovasc Electrophysiol. 2015. PMID: 25727361
Anxiety sensitivity moderates prognostic importance of rhythm-control versus rate-control strategies in patients with atrial fibrillation and congestive heart failure: insights from the Atrial Fibrillation and Congestive Heart Failure Trial.
Frasure-Smith N, Lespérance F, Talajic M, Khairy P, Dorian P, O'Meara E, Roy D. Frasure-Smith N, et al. Circ Heart Fail. 2012 May 1;5(3):322-30. doi: 10.1161/CIRCHEARTFAILURE.111.964122. Epub 2012 Mar 22. Circ Heart Fail. 2012. PMID: 22441774 Clinical Trial.
Prognostic value of the physical examination in patients with heart failure and atrial fibrillation: insights from the AF-CHF trial (atrial fibrillation and chronic heart failure).
Caldentey G, Khairy P, Roy D, Leduc H, Talajic M, Racine N, White M, O'Meara E, Guertin MC, Rouleau JL, Ducharme A. Caldentey G, et al. JACC Heart Fail. 2014 Feb;2(1):15-23. doi: 10.1016/j.jchf.2013.10.004. Epub 2014 Jan 8. JACC Heart Fail. 2014. PMID: 24622114 Free article. Clinical Trial.
Cardiac remodeling with rhythm versus rate control strategies for atrial fibrillation in patients with heart failure: insights from the AF-CHF echocardiographic sub-study.
Henrard V, Ducharme A, Khairy P, Gisbert A, Roy D, Levesque S, Talajic M, Thibault B, Racine N, White M, Guerra PG, Tardif JC; AF-CHF investigators. Henrard V, et al. Int J Cardiol. 2013 May 25;165(3):430-6. doi: 10.1016/j.ijcard.2011.08.077. Epub 2011 Sep 13. Int J Cardiol. 2013. PMID: 21917326 Clinical Trial.
ECG Features Associated With Adverse Cardiovascular Outcomes in Patients With Atrial Fibrillation: A Combined AFFIRM and AF-CHF Analysis.
Andrade JG, Roy D, Wyse DG, Dorian P, Talajic M, Leduc H, Cadrin-Tourigny J, Shohoudi A, Macle L, Thibault B, Guerra PG, Rivard L, Dubuc M, Khairy P. Andrade JG, et al. J Cardiovasc Electrophysiol. 2016 Apr;27(4):404-13. doi: 10.1111/jce.12934. Epub 2016 Feb 25. J Cardiovasc Electrophysiol. 2016. PMID: 27074775 Clinical Trial.